Control of melanoma cell invasion by type IV collagen

被引:57
作者
Pasco, S
Brassart, B
Ramont, L
Maquart, FX
Monboisse, JC
机构
[1] Univ Reims, CNRS, Biochim Lab, UMR 6198,IFR Biomol 53,UFR Med, F-51095 Reims, France
[2] Inst Curie, Lab Morphogenese Cellulaire & Progress Tumorale, CNRS, UMR 144, F-75248 Paris, France
来源
CANCER DETECTION AND PREVENTION | 2005年 / 29卷 / 03期
关键词
melanoma; type IV collagen; matrix metalloproteinase; integrin;
D O I
10.1016/j.cdp.2004.09.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant melanoma is the leading cause of death from diseases of the skin. This review summarizes the data from the literature and our laboratory addressing the effects of type IV collagen on melanoma progression. Many different sequences from type IV collagen promote melanoma cell adhesion, migration and invasion. The triple helical conformation of the collagenous domain plays a critical role in some of these interactions. However, recent studies from our group demonstrated that a sequence from the alpha 3(IV) NCl domain inhibits melanoma cell proliferation, migration and invasion by decreasing NIMP production and activation. Peptide sequences from the alpha 1(IV), alpha 2(IV) and alpha 3(IV) chains named arresten, canstatin and tumstatin, respectively were shown to inhibit angiogenesis. Further investigations regarding the inhibitory effects of the alpha(IV) NCl domains will have a paramount relevance for the design of efficient strategies to limit melanoma development. (c) 2004 International Society for Preventive Oncology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 54 条
[21]   The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens [J].
Knight, CG ;
Morton, LF ;
Peachey, AR ;
Tuckwell, DS ;
Farndale, RW ;
Barnes, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (01) :35-40
[22]   Identification in collagen type I of an integrin α2β1-binding site containing an essential GER sequence [J].
Knight, CG ;
Morton, LF ;
Onley, DJ ;
Peachey, AR ;
Messent, AJ ;
Smethurst, PA ;
Tuckwell, DS ;
Farndale, RW ;
Barnes, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33287-33294
[23]   INTEGRIN EXPRESSION IN MALIGNANT-MELANOMA [J].
KRAMER, RH ;
VU, M ;
CHENG, YF ;
RAMOS, DM .
CANCER AND METASTASIS REVIEWS, 1991, 10 (01) :49-59
[24]   Effect of ligand conformation on melanoma cell α3β1 integrin-mediated signal transduction events:: Implications for a collagen structural modulation mechanism of tumor cell invasion [J].
Lauer, JL ;
Gendron, CM ;
Fields, GB .
BIOCHEMISTRY, 1998, 37 (15) :5279-5287
[25]   Melanoma cell CD44 interaction with the α1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation [J].
Lauer-Fields, JL ;
Malkar, NB ;
Richet, G ;
Drauz, K ;
Fields, GB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :14321-14330
[26]   An all-D amino acid peptide model of alpha 1(IV)531-543 from type IV collagen binds the alpha(3)beta(1) integrin and mediates tumor cell adhesion, spreading, and motility [J].
Li, CF ;
McCarthy, JB ;
Furcht, LT ;
Fields, GB .
BIOCHEMISTRY, 1997, 36 (49) :15404-15410
[27]   Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties [J].
Maeshima, Y ;
Colorado, PC ;
Kalluri, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23745-23750
[28]   Distinct antitumor properties of a type IV collagen domain derived from basement membrane [J].
Maeshima, Y ;
Colorado, PC ;
Torre, A ;
Holthaus, KA ;
Grunkemeyer, JA ;
Ericksen, MB ;
Hopfer, H ;
Xiao, YW ;
Stillman, IE ;
Kalluri, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) :21340-21348
[29]   Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells [J].
Maquoi, E ;
Frankenne, F ;
Noël, A ;
Krell, HW ;
Grams, F ;
Foidart, JM .
EXPERIMENTAL CELL RESEARCH, 2000, 261 (02) :348-359
[30]   Down-regulation of MT1-MMP expression by the α3 chain of type IV collagen inhibits bronchial tumor cell line invasion [J].
Martinella-Catusse, C ;
Polette, M ;
Noel, A ;
Gilles, C ;
Dehan, P ;
Munaut, C ;
Colige, A ;
Volders, L ;
Monboisse, JC ;
Foidart, JM ;
Birembaut, P .
LABORATORY INVESTIGATION, 2001, 81 (02) :167-175